| The somatic genomic landscape of glioblastoma CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ... cell 155 (2), 462-477, 2013 | 5212 | 2013 |
| Prediction of central nervous system embryonal tumour outcome based on gene expression SL Pomeroy, P Tamayo, M Gaasenbeek, LM Sturla, M Angelo, ... Nature 415 (6870), 436-442, 2002 | 2863 | 2002 |
| Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer MD Burstein, A Tsimelzon, GM Poage, KR Covington, A Contreras, ... Clinical Cancer Research 21 (7), 1688-1698, 2015 | 1379 | 2015 |
| Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96 … A Gajjar, M Chintagumpala, D Ashley, S Kellie, LE Kun, TE Merchant, ... The lancet oncology 7 (10), 813-820, 2006 | 1053 | 2006 |
| Novel mutations target distinct subgroups of medulloblastoma G Robinson, M Parker, TA Kranenburg, C Lu, X Chen, L Ding, TN Phoenix, ... Nature 488 (7409), 43-48, 2012 | 954 | 2012 |
| Genome-wide association study identifies five susceptibility loci for glioma S Shete, FJ Hosking, LB Robertson, SE Dobbins, M Sanson, B Malmer, ... Nature genetics 41 (8), 899-904, 2009 | 903 | 2009 |
| Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome YJ Cho, A Tsherniak, P Tamayo, S Santagata, A Ligon, H Greulich, ... Journal of clinical oncology 29 (11), 1424-1430, 2011 | 857 | 2011 |
| Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations MC Thompson, C Fuller, TL Hogg, J Dalton, D Finkelstein, CC Lau, ... Journal of clinical oncology 24 (12), 1924-1931, 2006 | 833 | 2006 |
| Development of fuzzy algorithms for servo systems YF Li, CC Lau IEEE Control Systems Magazine 9 (3), 65-72, 1989 | 693 | 1989 |
| Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort S Smeland, SS Bielack, J Whelan, M Bernstein, P Hogendoorn, MD Krailo, ... European journal of cancer 109, 36-50, 2019 | 552 | 2019 |
| Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label … NM Marina, S Smeland, SS Bielack, M Bernstein, G Jovic, MD Krailo, ... The Lancet Oncology 17 (10), 1396-1408, 2016 | 533 | 2016 |
| Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good … SS Bielack, S Smeland, JS Whelan, N Marina, G Jovic, JM Hook, ... Journal of Clinical Oncology 33 (20), 2279-2287, 2015 | 415 | 2015 |
| Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles F Vega, CC Chang, LJ Medeiros, MM Udden, JH Cho-Vega, CC Lau, ... Modern Pathology 18 (6), 806-815, 2005 | 413 | 2005 |
| Mechanism by which caffeine potentiates lethality of nitrogen mustard. CC Lau, AB Pardee Proceedings of the national academy of sciences 79 (9), 2942-2946, 1982 | 393 | 1982 |
| EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment JS Whelan, SS Bielack, N Marina, S Smeland, G Jovic, JM Hook, M Krailo, ... Annals of oncology 26 (2), 407-414, 2015 | 366 | 2015 |
| Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma A Gajjar, R Hernan, M Kocak, C Fuller, Y Lee, PJ McKinnon, D Wallace, ... Journal of Clinical Oncology 22 (6), 984-993, 2004 | 353 | 2004 |
| Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors BS Melin, JS Barnholtz-Sloan, MR Wrensch, C Johansen, D Il'Yasova, ... Nature genetics 49 (5), 789-794, 2017 | 348 | 2017 |
| Genome-wide association study of glioma and meta-analysis P Rajaraman, BS Melin, Z Wang, R McKean-Cowdin, DS Michaud, ... Human genetics 131, 1877-1888, 2012 | 290 | 2012 |
| Frequent amplification of a chr19q13. 41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors M Li, KF Lee, Y Lu, I Clarke, D Shih, C Eberhart, VP Collins, T Van Meter, ... Cancer cell 16 (6), 533-546, 2009 | 284 | 2009 |
| Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC XN Li, Q Shu, JMF Su, L Perlaky, SM Blaney, CC Lau Molecular cancer therapeutics 4 (12), 1912-1922, 2005 | 263 | 2005 |
